A Study to Learn About the Vaccine RSVpreF in Pregnant Participants with HIV and Their Infants
Final Report: A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Immunogenicity of Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Pregnant Participants Living with HIV and Their Infants
Category & Conditions: Vaccine-related Conditions
Medicine: PF-06928316
ClinicalTrials.gov Identifier (NCT): NCT06325657
Protocol ID: C3671032
Report Type: Final
Language: English
Open Plain Language Summary Result:
Click here